申请人:Blurton Peter
公开号:US20100204230A1
公开(公告)日:2010-08-12
Compounds of formula (I) selectively inhibit production of Aβ(1-42) and hence find use in treatment of Alzheimer's disease and other conditions associated with deposition of A(β) in the brain.
公式(I)的化合物选择性地抑制Aβ(1-42)的产生,因此可用于治疗阿尔茨海默病和其他与Aβ在脑中沉积有关的疾病。